The Sydney system for lymph node FNA biopsy cytopathology: A detailed analysis of recent publications and meta‐analysis and a proposal for the components of an ideal prospective study of a cytopathology reporting system
Cancer Cytopathology · 2024
DOI: 10.1002/cncy.22890 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Cancer Cytopathology, 2024. Verfasst von Sharron Liang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical Pathology, St. Vincent's Hospital and University of NSW, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Lymph Nodes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The Sydney system for fine‐needle aspiration biopsy of lymph nodes has five categories, stressing the role of correlation of cytopathology with clinical, ultrasound, and ancillary findings to achieve diagnosis. The five categories constitute a hierarchical system with increasing risk of malignancy from benign to atypical, suspicious, and malignant categories, which informs recommendations for further workup to achieve a final diagnosis as possible. This article analyzes 10 publications using the Sydney system and a meta‐analysis of nine of these studies. The primary goal of the analysis is to ascertain the causes of the large ranges in risk of malignancy for the “atypical” and “inadequate” compared to “benign,” “suspicious,” and “malignant” categories, which were comparable to well‐established reporting systems. Research protocols are proposed to improve future studies.
Methods
PubMed literature search from January 2021 to December 2023 identified studies evaluating performance of the Sydney system.
Results
Ten studies showed heterogeneity with clinical setting, study design, ultrasound use and rapid on‐site evaluation, operator, cutoff points for “positive” cases, with inherent partial verification biases, resulting in a wide range of risk of malignancy, specificity, and sensitivity values.
Conclusion
Analysis shows the large range is due to heterogeneity of the studies, which suffer from biases and variable statistical analysis that are ultimately included in any meta‐analysis, detracting from the usefulness of the risk of malignancy derived by the meta‐analysis. Components for ideal analyses of reporting systems are presented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomical Pathology, St. Vincent's Hospital and University of NSW, Sydney, New South Wales, Australia.
- Medical School, University of NSW Sydney, Sydney, New South Wales, Australia.
- Vanvitalli University of Naples, Naples, Italy.
- University of Salerno, Pathology Institute, AOU San Giovanni di Dio e Ruggi d'Aragona, Salerno, Fisciano, Italy.
- Medical School, Notre Dame University Sydney, Sydney, New South Wales, Australia.
ORCID-Profile: Sharron Liang, Pio Zeppa, Andrew S Field
Zitieren
APA
Liang, S., Cozzolino, I., Zeppa, P., & Field, A. S. (2024). The Sydney system for lymph node FNA biopsy cytopathology: A detailed analysis of recent publications and meta‐analysis and a proposal for the components of an ideal prospective study of a cytopathology reporting system. Cancer Cytopathology. https://doi.org/10.1002/cncy.22890
Vancouver
Liang S, Cozzolino I, Zeppa P, Field AS. The Sydney system for lymph node FNA biopsy cytopathology: A detailed analysis of recent publications and meta‐analysis and a proposal for the components of an ideal prospective study of a cytopathology reporting system. Cancer Cytopathology. 2024. doi:10.1002/cncy.22890
BibTeX
@article{Liang2024,
author = {Liang, Sharron and Cozzolino, Immacolata and Zeppa, Pio and Field, Andrew S},
title = {The Sydney system for lymph node FNA biopsy cytopathology: A detailed analysis of recent publications and meta‐analysis and a proposal for the components of an ideal prospective study of a cytopathology reporting system},
journal = {Cancer Cytopathology},
year = {2024},
doi = {10.1002/cncy.22890}
}
EUVIMED